KYMR
Kymera Therapeutics Inc
109.30$
+0.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +92.9% | +87.0% | -4.1% | +342.0% | -12.0% | +46.3% | -1.0% | +9.8% | -24.9% | -37.0% | +19.7% | -17.0% | +69.0% | -41.3% | +74.4% | -71.4% | +912.8% | -78.5% | +149.3% | -85.4% | +97.6% | +198.9% | -48.1% | -75.9% | +3.5% | +1,101.6% | +89.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +6,168.1% | -98.1% | +10.0% | +0.0% | +0.0% | -3.9% | +73.4% | +26.7% | +5.3% | -1.3% | +3.8% | +1.8% | +3,455.4% | -202.8% | – | – | – | |
| – | +92.9% | +87.0% | -4.1% | +342.0% | -12.0% | +46.3% | -1.0% | +9.8% | -24.9% | -37.0% | +19.7% | -17.0% | +69.0% | -41.3% | +74.4% | -71.4% | +912.8% | -78.5% | +149.3% | -85.4% | +97.6% | +198.9% | -57.5% | -859.5% | – | -56.5% | +89.1% | – | |
| – | -2.0% | +9.3% | +14.1% | +14.2% | +29.2% | +27.3% | +35.7% | +8.8% | -2.0% | -4.2% | +14.9% | +6.3% | -1.7% | -2.1% | +8.4% | +5.1% | +10.1% | -7.8% | +21.3% | +2.0% | +18.9% | +11.7% | -2.3% | -5.5% | +13.2% | +17.1% | +21.7% | – | |
| – | +68.6% | +1.1% | +43.1% | +86.8% | -24.3% | +14.2% | +35.9% | +32.9% | +10.1% | -9.6% | +4.0% | -4.3% | +10.2% | +8.0% | +12.4% | -0.1% | +0.8% | +1.0% | +20.9% | -11.0% | +5.7% | -0.4% | +8.4% | -1.8% | -2.2% | +20.1% | +3.8% | – | |
| – | +6.3% | +7.8% | +19.1% | +29.4% | +13.0% | +24.7% | +35.7% | +13.2% | +0.6% | -5.5% | +12.4% | +4.0% | +0.6% | +0.0% | +9.3% | +3.9% | +8.0% | +1.4% | +12.4% | -0.9% | +16.2% | +9.5% | -2.7% | -77.4% | +734.9% | -33.0% | +18.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +650.0% | +13.3% | -26.5% | +12.0% | -3.6% | -11.1% | +16.7% | +150.0% | -28.6% | -18.0% | +0.0% | -12.2% | +61.1% | -5.2% | -12.7% | -14.6% | +26.8% | +32.7% | -11.6% | -1.6% | -1.7% | +22.0% | +50.0% | -9.3% | -29.6% | -11.6% | +32.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -32.6% | +16.3% | -34.7% | -45.2% | -398.4% | – | -16.9% | +27.6% | -59.2% | -588.2% | – | – | -142.7% | – | – | -119.3% | – | -99.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.